Observe Medical ASA: New share capital registered

17 Dec 2024 19:30 CET

Oslo, 17 December 2024

Reference is made to the announcement by Observe Medical ASA (the "Company" or
"Observe Medical", OSE ticker "OBSVR") on 5 December 2024 regarding the final
results of the subsequent offering in the Company and the waiver of the
condition for completion of the share capital increase of NOK 10,630,629.88,
through the issuance of 40,887,038 new shares to Navamedic ASA, at a
subscription price of 0.40 per share, in connection with the conversion by
Navamedic ASA of a loan amount of NOK 16,354,815.20 under a loan from Navamedic
ASA to the Company (the "Loan Conversion").

The Loan Conversion has today been completed through the registration of the
share capital increase pertaining to the Loan Conversion with the Norwegian
Register of Business Enterprises (Nw. Foretaksregisteret). The Company's
registered share capital is NOK 75,107,805.50 divided into 288,876,175 shares,
each with a nominal value of NOK 0.26.

The new shares will be issued in the Norwegian Central Securities Depository (ES
-OSL) on the listed ISIN NO 0010865009 and are expected to be delivered to
Navamedic ASA's ES-OSL account later today on 17 December 2024.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

More information:
Access the news on Oslo Bors NewsWeb site